Attached files
| file | filename |
|---|---|
| EX-10.14 - EX-10.14 - Talis Biomedical Corp | d25171dex1014.htm |
| EX-10.13 - EX-10.13 - Talis Biomedical Corp | d25171dex1013.htm |
| EX-10.12 - EX-10.12 - Talis Biomedical Corp | d25171dex1012.htm |
| EX-10.11 - EX-10.11 - Talis Biomedical Corp | d25171dex1011.htm |
| EX-10.10 - EX-10.10 - Talis Biomedical Corp | d25171dex1010.htm |
| EX-10.9 - EX-10.9 - Talis Biomedical Corp | d25171dex109.htm |
| EX-10.8 - EX-10.8 - Talis Biomedical Corp | d25171dex108.htm |
| EX-10.7 - EX-10.7 - Talis Biomedical Corp | d25171dex107.htm |
| EX-10.2 - EX-10.2 - Talis Biomedical Corp | d25171dex102.htm |
| EX-10.1 - EX-10.1 - Talis Biomedical Corp | d25171dex101.htm |
| EX-4.3 - EX-4.3 - Talis Biomedical Corp | d25171dex43.htm |
| EX-4.2 - EX-4.2 - Talis Biomedical Corp | d25171dex42.htm |
| EX-3.3 - EX-3.3 - Talis Biomedical Corp | d25171dex33.htm |
| EX-3.1 - EX-3.1 - Talis Biomedical Corp | d25171dex31.htm |
| S-1 - S-1 - Talis Biomedical Corp | d25171ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated October 15, 2020, in the Registration Statement (Form S-1) and related Prospectus of Talis Biomedical Corporation dated January 22, 2021.
/s/ Ernst & Young LLP
Redwood City, California
January 22, 2021